Tapping our microbiomes for new health treatments

Fecal transplants for treating gut diseases were the first reported therapies based on the idea that the human microbiome is inextricably linked to our health. Now, as researchers further flesh out this connection, dozens ...

Sanofi-Aventis says gets US approval for Genzyme bid

French pharmaceutical giant Sanofi-Aventis said on Wednesday that US competition authorities had not raised any objections to its hostile bid for US biotechnology group and rare disease specialist Genzyme.

Delivering drugs on time and on target

(PhysOrg.com) -- Northeastern professor leading research on nanocarriers that would make a whole new class of drugs available to treat cancer and other diseases

New or not? Cracking cyclic natural products for new drugs

Researchers have invented computational tools to decode and rapidly determine whether natural compounds collected in oceans and forests are new—or if these pharmaceutically promising compounds have already been described ...